Capital International Investors Crispr Therapeutics Ag Transaction History
Capital International Investors
- $488 Billion
- Q1 2025
A detailed history of Capital International Investors transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Capital International Investors holds 6,073,118 shares of CRSP stock, worth $335 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,073,118
Previous 8,743,523
30.54%
Holding current value
$335 Million
Previous $344 Million
39.95%
% of portfolio
0.04%
Previous 0.07%
Shares
22 transactions
Others Institutions Holding CRSP
# of Institutions
475Shares Held
64.2MCall Options Held
2.16MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$560 Million3.73% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$209 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$153 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$140 Million1.16% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$140 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.3B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....